He was treated with every other week Gem-nab-pac
🙏@GIcancerDoc
➡️Had rapid symptomatic improvement
➡️Now essentially normal PS
➡️Nice response to treatment for 9 months🙂
✅Patient started on encoraf+binimet
➡️Did very well
➡️PR for 12 months
Shameless plug: PLEASE CONSIDER referring to our clinical trial of encoraf+binimet in BRAFV600E-mut #PancreaticCancer NCT04390243
✅Any # of prior lines of Tx
➡️R-H Xu, et al (abstr 4000)
✅Ph 3 trial of camrelizumab plus chemo vs. chemo in patients with advanced esophageal SCC
👉Paclitaxel + cis +/- camrelizumab
👉596 patients randomized
🎉Camrelizumab plus chemotherapy⬆️mOS (15.3 vs. 12.0 mos) and ⬆️ORR (72.1% vs. 62.1%)
Alison M. Schram, @EileenMOReilly@graokane@benweinbergmd (abstr 3003)
➡️Zenocutuzumab (MCLA-128) in pancreas cancer and other solid tumors harboring NRG1 fusions